Blog

CV Risk in RA: Questions Remain

TARGET study should fill in the clinical gaps

ORLANDO — Evidence continues to grow supporting the concept that reducing inflammation in patients with rheumatoid arthritis (RA) will not only improve their articular symptoms but also lower their cardiovascular (CV) risk, a researcher said at the annual meeting of the Florida Society of Rheumatology here.

Read Full Article

Archive

Contributors

    Archive

    Contributors